Intiland Development Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intiland Development Tbk. trades at Rp114 (market cap 1.2T, 13.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Intiland Development Tbk. is far larger — about 7.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Intiland Development Tbk. is more actively traded (13.47M versus 187.4K). Which is the better fit depends on your goals.
| DILD | OBAT | |
|---|---|---|
Market Cap | 1.2T | 164.65B |
Volume | 13.47M | 187.4K |
Lot | 134.73K | 1.87K |
Turnover | 1.54B | 44.35M |
Average Price | 114.29 | 236.67 |
Value | 1.54B | 44.35M |
Indicative Equilibrium Price | 114 | 242 |
Indicative Equilibrium Volume | 146 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Read more on DILD →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →